Literature DB >> 2741944

Hypopigmentation: a common feature of Prader-Labhart-Willi syndrome.

M G Butler1.   

Abstract

In order to determine the frequency and characterization of hypopigmentation in Prader-Labhart-Willi syndrome (PLWS), clinical, cytogenetic and biochemical findings are reported in 56 PLWS individuals. Forty-eight percent of the individuals with PLWS met the criteria for hypopigmentation. Hypopigmentation in PLWS individuals appears to be as common as previously recognized features such as behavioral problems and dental abnormalities. Significant differences in hair color, sun sensitivity, and complexion were found between those PLWS patients with the chromosome 15 deletion and those with normal chromosomes. Individuals with the deletion frequently had lighter hair color, more sun sensitivity, and fairer complexion than did either other family members or nondeletion PLWS patients. No significant differences in biochemical findings (phenylalanine, tyrosine, catecholamines, or beta-melanocyte-stimulating hormone) were found between deletion and nondeletion PLWS patients or between hypopigmented and normally pigmented patients. The data suggest that a gene(s) controlling the activity of tyrosinase or other enzymes required for melanin production is located on proximal 15q.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2741944      PMCID: PMC1683374     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  12 in total

Review 1.  Recurrence risk in the Angelman ("happy puppet") syndrome.

Authors:  P J Willems; I Dijkstra; O F Brouwer; G P Smit
Journal:  Am J Med Genet       Date:  1987-08

2.  The Angelman ("happy puppet") syndrome.

Authors:  C A Williams; J L Frias
Journal:  Am J Med Genet       Date:  1982-04

Review 3.  Chromosome 15 anomalies and the Prader-Willi syndrome: cytogenetic analysis.

Authors:  M G Mattei; N Souiah; J F Mattei
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

4.  Plasma immunoreactive beta-melanocyte stimulating hormone (lipotropin) levels in individuals with Prader-Labhart-Willi syndrome.

Authors:  M G Butler; B B Jenkins; D N Orth
Journal:  Am J Med Genet       Date:  1987-12

5.  Is Angelman syndrome an alternate result of del(15)(q11q13)?

Authors:  R E Magenis; M G Brown; D A Lacy; S Budden; S LaFranchi
Journal:  Am J Med Genet       Date:  1987-12

6.  Oculocutaneous albinoidism as a manifestation of reduced neural crest derivatives in the Prader-Willi syndrome.

Authors:  H M Hittner; R A King; V M Riccardi; D H Ledbetter; R P Borda; R E Ferrell; F L Kretzer
Journal:  Am J Ophthalmol       Date:  1982-09       Impact factor: 5.258

7.  Chromosome 15 abnormalities and the Prader-Willi syndrome: a follow-up report of 40 cases.

Authors:  D H Ledbetter; J T Mascarello; V M Riccardi; V D Harper; S D Airhart; R J Strobel
Journal:  Am J Hum Genet       Date:  1982-03       Impact factor: 11.025

8.  Rapid radioimmunoassay for corticotropin in unextracted human plasma.

Authors:  W E Nicholson; D R Davis; B J Sherrell; D N Orth
Journal:  Clin Chem       Date:  1984-02       Impact factor: 8.327

9.  Abnormalities of the central visual pathways in Prader-Willi syndrome associated with hypopigmentation.

Authors:  D J Creel; C M Bendel; G L Wiesner; J D Wirtschafter; D C Arthur; R A King
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

10.  Hypopigmentation in the Prader-Willi syndrome.

Authors:  G L Wiesner; C M Bendel; D P Olds; J G White; D C Arthur; D W Ball; R A King
Journal:  Am J Hum Genet       Date:  1987-05       Impact factor: 11.025

View more
  31 in total

1.  The p locus is closely linked to the mouse homolog of a gene from the Prader-Willi chromosomal region.

Authors:  Y Nakatsu; Y Gondo; M H Brilliant
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  The tyrosinase-positive oculocutaneous albinism locus maps to chromosome 15q11.2-q12.

Authors:  M Ramsay; M A Colman; G Stevens; E Zwane; J Kromberg; M Farrall; T Jenkins
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

3.  The frequency of uniparental disomy in Prader-Willi syndrome. Implications for molecular diagnosis.

Authors:  M J Mascari; W Gottlieb; P K Rogan; M G Butler; D A Waller; J A Armour; A J Jeffreys; R L Ladda; R D Nicholls
Journal:  N Engl J Med       Date:  1992-06-11       Impact factor: 91.245

4.  Somatic recombination rather than uniparental disomy suggested as another mechanism by which genetic imprinting may play a role in the etiology of Prader-Willi syndrome.

Authors:  C A Gregory; J Schwartz; A J Kirkilionis; N Rudd; J L Hamerton
Journal:  Hum Genet       Date:  1991-11       Impact factor: 4.132

5.  Hypopigmentation in the Prader-Willi syndrome correlates with P gene deletion but not with haplotype of the hemizygous P allele.

Authors:  R A Spritz; T Bailin; R D Nicholls; S T Lee; S K Park; M J Mascari; M G Butler
Journal:  Am J Med Genet       Date:  1997-07-11

6.  Prader-Willi Syndrome: Clinical and Genetic Findings.

Authors:  Merlin G Butler; Travis Thompson
Journal:  Endocrinologist       Date:  2000-07

7.  EVALUATION OF PLASMA SUBSTANCE P AND BETA-ENDORPHIN LEVELS IN CHILDREN WITH PRADER-WILLI SYNDROME.

Authors:  M G Butler; T A Nelson; D J Driscoll; A M Manzardo
Journal:  J Rare Disord       Date:  2015-09

8.  Mosaic loss of 15q11q13 in a patient with hypomelanosis of Ito: is there a role for the P gene?

Authors:  J E Pellegrino; R E Schnur; R Kline; E H Zackai; N B Spinner
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

9.  Prader-Willi syndrome.

Authors:  Suzanne B Cassidy; Daniel J Driscoll
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

10.  Evaluation of potential models for imprinted and nonimprinted components of human chromosome 15q11-q13 syndromes by fine-structure homology mapping in the mouse.

Authors:  R D Nicholls; W Gottlieb; L B Russell; M Davda; B Horsthemke; E M Rinchik
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.